Linked Life Data

8650487

Source:http://linkedlifedata.com/resource/pubmed/id/8650487

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1996-7-22
pubmed:abstractText
There are no controlled clinical trials evaluating drug therapy in patients with ventricular arrhythmias and chronic chagasic cardiomyopathy. Empirical treatment with disopyramide (400-1, 1,000mg/d), phenytoin (4-6mg/d), mexiletine 600-1,200mg/d), propafenone (900mg/d), amiodarone (loading: 1,000mg/d, 10-14 days; maintenance 200-600mg/d), and sotalol (320mg/d) had efficacy and tolerance ranging from 18% to 90% with heterogeneous criteria for efficacy definition. Further studies with homogenous criteria are required to determine which is most appropriate drug therapy for patients with chronic chagasic cardiomyopathy and ventricular arrhythmias.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1516-3180
pubmed:author
pubmed:issnType
Print
pubmed:volume
113
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
858-61
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:articleTitle
Medical treatment of cardiac arrhythmias in Chagas' heart disease.
pubmed:affiliation
Escola Paulista de Medicina - São Paulo, Brazil.
pubmed:publicationType
Journal Article, Comparative Study, Review